Haemonetics Corporation Share Price

Haemonetics Corporation Share Price

NYSE: HAE | Mid Cap
$120.05
+$1.86 (1.57%) Last updated on 29 Oct, 2026 | 20:37 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Haemonetics Corporation Stock Performance

Open
$119.20
Prev. Close
$118.19
Circuit Range
N/A
Day Range
$118.49 - $120.11
Year Range
$48.98 - $123.50
Volume
5,879
Average Traded
$119.46

Haemonetics Corporation Share Price Today

As of 29 October 2026, Haemonetics Corporation's share price is $120.05. The stock opened at $119.20, compared to its previous close of $118.19. During today's trading session, Haemonetics Corporation's share price traded between $118.49 and $120.11, with an average price of $119.30. Over the past 52 weeks, the stock has recorded a high of $123.50 and a low of $48.98. In terms of performance, Haemonetics Corporation's share price has risen by 99.95% over the last six months and is up 140.00% on a year-on-year basis.

Haemonetics Corporation Share Price Chart

Line chart of the Haemonetics Corporation price trend over the selected period. The price rose overall, ranging from 118.49 to 120.18, ending at 120.05.
$118.49$120.11
L
Show Current Price
H

Haemonetics Corporation Stock Fundamentals & Key Indicators

Market Cap
$6.04B
PE Ratio (TTM)
56.69
Dividend Yield
0.00%
EPS (TTM)
$2.12
Revenue (TTM)
$1.33T
Return On Equity (TTM)
11.50%
Profit Margin
7.29%
Debt to Equity
1.40
Quarterly Earnings Growth YoY
-14.66%

Haemonetics Corporation Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$327.32$338.97$346.35$339.38
Net Profit$38.68$44.74-$20.15$33.01
Net Profit Margin11.82%13.20%-5.82%9.73%
Income ChangeN/A15.67%-145.04%263.82%

Haemonetics Corporation Annual Profit & Loss

All figures in USD

Particulars2023202420252026
Revenue$1168.66$1309.06$1360.82$1334.03
Net Profit$115.40$117.56$167.68$97.31
Net Profit Margin9.87%8.98%12.32%7.29%
Income ChangeN/A1.87%42.63%-41.97%

About Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The Plasma segment includes end-to-end collection technologies, automated plasmapheresis systems (such as the NexSys PCS device), and donor management software designed for commercial plasma collectors. Hospital segment includes Blood Management Technologies (hemostasis analyzers, cell salvage systems) and Interventional Technologies. And the Blood Center provides solutions and devices enabling blood centers to harvest essential components like platelets and red blood cells.

Haemonetics Corporation Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$105.58
$120.05
+13.71%
Sep 2026
$101.19
$105.58
+0.56%
Aug 2026
$86.34
$104.99
+22.64%
Jul 2026
$75.88
$85.61
+13.87%
Jun 2026
$66.11
$75.18
+10.65%
May 2026
$59.77
$67.94
+13.17%
Apr 2026
$56.48
$60.04
+6.61%
Mar 2026
$63.02
$56.32
-10.98%
Feb 2026
$66.16
$63.27
-5.09%
Jan 2026
$80.53
$66.66
-16.77%
Dec 2025
$81.56
$80.09
-1.62%
Nov 2025
$49.59
$81.41
+62.74%

HAE Share Price FAQs